Iris-Melanie Noebauer-Huhmann,Filip M. Vanhoenacker,Joan C. Vilanova,Alberto S. Tagliafico,Marc-André Weber,Radhesh K. Lalam,Thomas Grieser,Violeta Vasilevska Nikodinovska,Jacky W. J. de Rooy,Olympia Papakonstantinou,Catherine Mccarthy,Luca Maria Sconfienza,Koenraad Verstraete,José Martel-Villagrán,Pavol Szomolanyi,Frédéric E. Lecouvet,Diana Afonso,Omar M. Albtoush,Giacomo Aringhieri,Remide Arkun,Gunnar Aström,Alberto Bazzocchi,Rajesh Botchu,Martin Breitenseher,Snehansh Chaudhary,Danoob Dalili,Mark Davies,Milko C. de Jonge,Berna D. Mete,Jan Fritz,Jan L. M. A. Gielen,Geoff Hide,Amanda Isaac,Slavcho Ivanoski,Ramy M. Mansour,Lorenzo Muntaner-Gimbernat,Ana Navas,Paul O´Donnell,Şebnem Örgüç,Winston Rennie,Santiago Resano,Philip Robinson,Hatice T. Sanal,Simone A. J. Ter Horst,Kirsten van Langevelde,Klaus Wörtler,Marita Koelz,Joannis Panotopoulos,Reinhard Windhager,Johannes L. Bloem

Abstract:Abstract Objectives Early, accurate diagnosis is crucial for the prognosis of patients with soft tissue sarcomas. To this end, standardization of imaging algorithms, technical requirements, and reporting is therefore a prerequisite. Since the first European Society of Musculoskeletal Radiology (ESSR) consensus in 2015, technical achievements, further insights into specific entities, and the revised WHO-classification (2020) and AJCC staging system (2017) made an update necessary. The guidelines are intended to support radiologists in their decision-making and contribute to interdisciplinary tumor board discussions. Materials and methods A validated Delphi method based on peer-reviewed literature was used to derive consensus among a panel of 46 specialized musculoskeletal radiologists from 12 European countries. Statements were scored online by level of agreement (0 to 10) during two iterative rounds. Either “group consensus,” “group agreement,” or “lack of agreement” was achieved. Results Eight sections were defined that finally contained 145 statements with comments. Overall, group consensus was reached in 95.9%, and group agreement in 4.1%. This communication contains the first part consisting of the imaging algorithm for suspected soft tissue tumors, methods for local imaging, and the role of tumor centers. Conclusion Ultrasound represents the initial triage imaging modality for accessible and small tumors. MRI is the modality of choice for the characterization and local staging of most soft tissue tumors. CT is indicated in special situations. In suspicious or likely malignant tumors, a specialist tumor center should be contacted for referral or teleradiologic second opinion. This should be done before performing a biopsy, without exception. Clinical relevance The updated ESSR soft tissue tumor imaging guidelines aim to provide best practice expert consensus for standardized imaging, to support radiologists in their decision-making, and to improve examination comparability both in individual patients and in future studies on individualized strategies. Key Points • Ultrasound remains the best initial triage imaging modality for accessible and small suspected soft tissue tumors. • MRI is the modality of choice for the characterization and local staging of soft tissue tumors in most cases; CT is indicated in special situations. Suspicious or likely malignant tumors should undergo biopsy. • In patients with large, indeterminate or suspicious tumors, a tumor reference center should be contacted for referral or teleradiologic second opinion; this must be done before a biopsy.

Imaging of pediatric extragonadal pelvic soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper

Unusual imaging findings associated with abdominal pediatric germ cell tumors

Imaging of Pediatric Testicular and Para-Testicular Tumors: A Pictural Review

Imaging of pediatric gastrointestinal tumors: A tertiary center experience over 19 years

Pediatric presacral tumors with intraspinal extension: a rare entity with diagnostic challenges

Soft tissue tumor imaging in adults: whole-body staging in sarcoma, non-malignant entities requiring special algorithms, pitfalls and special imaging aspects. Guidelines 2024 from the European Society of Musculoskeletal Radiology (ESSR)

Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2023—overview, and primary local imaging: how and where?

Imaging pediatric bone sarcomas. Diagnosis and treatment-related issues

PET/CT and PET/MR in Soft Tissue Sarcoma: An Update

Critical elements of pediatrics sacrococcygeal germ cell tumor surgery

[Imaging of abdominal tumors in childhood and adolescence : Part II: relevant intra-abdominal and retroperitoneal tumor entities]

Imaging Appearance of Nongerminoma Pediatric Ovarian Germ Cell Tumors Does Not Discriminate Benign from Malignant Histology

Positron emission tomography in the diagnosis and management of primary pediatric lung tumors

Extragonadal Germ Cell Tumors: A Review With Emphasis on Pathologic Features, Clinical Prognostic Variables, and Differential Diagnostic Considerations

Current Treatment for Wilms Tumor: COG and SIOP Standards

Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM

Pearls and Pitfalls in the Imaging of Soft-Tissue Masses in Children

Pediatric orbital lesions: neoplastic extraocular soft-tissue lesions

Imaging in rhabdomyosarcoma: a patient journey

Imaging in pelvic exenteration—a multidisciplinary practice guide from the ESGAR-SAR-ESUR-PelvEx collaborative group

Imaging Guidelines and Recommendations for Diagnosis, Surveillance, and Management of Pediatric CNS and Spinal Tumors